A number of firms have modified their ratings and price targets on shares of Dynatrace (NYSE: DT) recently: 9/15/2026 – Dynatrace had its “buy” rating reaffirmed by UBS Group AG. 9/15/2026 – Dynatrace had its price target raised by BMO Capital Markets from $60.00 to $62.00. They now have an “outperform” rating on the stock. […]

Several analysts have recently updated their ratings and price targets for Airbnb (NASDAQ: ABNB): 9/16/2026 – Airbnb is now covered by Morgan Stanley. They set an “equal weight” rating and a $170.00 price target on the stock. 9/10/2026 – Airbnb had its price target raised by Truist Financial Corporation from $134.00 to $161.00. They now […]

A number of firms have modified their ratings and price targets on shares of Zymeworks (NASDAQ: ZYME) recently: 9/3/2026 – Zymeworks had its price target raised by JPMorgan Chase & Co. from $31.00 to $33.00. They now have an “overweight” rating on the stock. 8/26/2026 – Zymeworks was given a new $32.00 price target by […]

A number of research firms have changed their ratings and price targets for Attovia Therapeutics (NASDAQ: ATTO): 9/4/2026 – Attovia Therapeutics was upgraded by Zacks Research to “hold”. 8/31/2026 – Attovia Therapeutics is now covered by Lifesci Capital. They set an “outperform” rating and a $45.00 price target on the stock. 8/31/2026 – Attovia Therapeutics […]

Ooma (NYSE: OOMA) has recently received a number of price target changes and ratings updates: 8/27/2026 – Ooma had its “buy” rating reaffirmed by UBS Group AG. 8/27/2026 – Ooma had its “buy” rating reaffirmed by Lake Street Capital. They now have a $25.00 price target on the stock. 8/27/2026 – Ooma had its price […]

Several brokerages have updated their recommendations and price targets on shares of Toronto-Dominion Bank (TSE: TD) in the last few weeks: 9/3/2026 – Toronto-Dominion Bank had its price target raised by Canadian Imperial Bank of Commerce from C$184.00 to C$188.00. They now have a “neutral” rating on the stock. 9/3/2026 – Toronto-Dominion Bank had its […]